Please enable JavaScript to continue using this application.

Compare $AGIO vs $PVLA | Chartloom

Compare

$AGIO vs $PVLA

Agios Pharmaceuticals Inc · Palvella Therapeutics Inc

AGIO

Agios Pharmaceuticals Inc

PVLA

Palvella Therapeutics Inc

Compare $AGIO vs $PVLA

Comparing Agios Pharmaceuticals Inc and Palvella Therapeutics Inc

AGIOAgios Pharmaceuticals Inc

PVLAPalvella Therapeutics Inc

AGIOAgios Pharmaceuticals Inc

Market cap

$1.89B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.91x

Rev growth (TTM)

140.6%

YTD performance

17.0%

52W performance

-25.3%

FCF yield

-19.3%

PVLAPalvella Therapeutics Inc

Market cap

$1.99B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-97.2%

YTD performance

38.4%

52W performance

85.4%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGIO

PVLA

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

PVLA

Palvella Therapeutics Inc

Market Cap

AGIO$1.89B

PVLA$1.99B

Enterprise Value

AGIO$1.79B

PVLA$1.82B

Price

AGIO$31.81

PVLA$138.77

P/E Ratio

AGION/A

PVLAN/A

P/S Ratio

AGIO19.24x

PVLA46.64x

EV/Sales

AGIO18.22x

PVLA0.00x

EV/EBITDA

AGIO2.84x

PVLA0.00x

P/B Ratio

AGIO1.85x

PVLA8.80x

P/FCF Ratio

AGION/A

PVLAN/A

EV/FCF

AGIO-4.91x

PVLA-49.96x

PEG Ratio

AGION/A

PVLAN/A

Forward P/E (NTM)

AGION/A

PVLAN/A

Forward P/S (NTM)

AGIO6.91x

PVLAN/A

Revenue (TTM)

AGIO$98M

PVLA$0

Revenue Growth (YoY)

AGIO140.6%

PVLA-97.2%

Forward Rev Growth

AGIO92.6%

PVLA287.4%

Gross Margin (TTM)

AGIO92.0%

PVLA0.0%

Operating Margin (TTM)

AGIO0.0%

PVLA0.0%

EBITDA Margin (TTM)

AGIO-461.3%

PVLA0.0%

Net Margin (TTM)

AGIO-418.2%

PVLA0.0%

FCF Margin (TTM)

AGIO-371.4%

PVLAN/A

Net Income (TTM)

AGIO$-411M

PVLA$-62M

FCF (TTM)

AGIO$-365M

PVLA$-37M

EPS (TTM)

AGIO-$6.91

PVLA-$4.30

ROE (TTM)

AGIO-3567.0%

PVLA-4784.0%

ROA (TTM)

AGIO-3306.0%

PVLA-3833.0%

ROIC (TTM)

AGIO-3567.0%

PVLA-4172.0%

Cash

AGIO$100M

PVLA$188M

Debt

AGIO$0

PVLA$22M

Net Cash/Debt

AGIO$100M

PVLA$166M

Current Ratio (TTM)

AGIO10.22x

PVLA21.18x

Quick Ratio (TTM)

AGIO9.14x

PVLA21.01x

Debt/Equity (TTM)

AGIO0.00x

PVLA0.10x

Debt/Assets (TTM)

AGIO0.0%

PVLA0.0%

Interest Coverage (TTM)

AGION/A

PVLAN/A

Net Debt/EBITDA (TTM)

AGIO0.00x

PVLA0.00x

Beta

AGIO0.62

PVLA-0.19

52W Performance

AGIO-25.3%

PVLA85.4%

YTD Performance

AGIO17.0%

PVLA38.4%

% from 52W High

AGIO-30.8%

PVLA-14.0%

% from 52W Low

AGIO43.0%

PVLA110.5%

Asset Turnover (TTM)

AGIO0.08x

PVLA0.76x

FCF Yield (TTM)

AGIO-19.3%

PVLA-1.8%

Earnings Yield (TTM)

AGIO-21.7%

PVLA-3.1%

Dividend Yield (TTM)

AGION/A

PVLAN/A

Rule of 40

AGIO-230.8

PVLA-97.2

EV/GP/RG

AGIO0.06

PVLAN/A

Ticker research

View AGIO research View PVLA research

Metric	AGIO Agios Pharmaceuticals Inc	PVLA Palvella Therapeutics Inc
Market & Valuation
Market Cap	$1.89B	$1.99B
Enterprise Value	$1.79B	$1.82B
Price	$31.81	$138.77
P/E Ratio	N/A	N/A
P/S Ratio	19.24x	46.64x
EV/Sales	18.22x	0.00x
EV/EBITDA	2.84x	0.00x
P/B Ratio	1.85x	8.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.91x	-49.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.91x	N/A
Revenue & Growth
Revenue (TTM)	$98M	$0
Revenue Growth (YoY)	140.6%	-97.2%
Forward Rev Growth	92.6%	287.4%
Profitability
Gross Margin (TTM)	92.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-461.3%	0.0%
Net Margin (TTM)	-418.2%	0.0%
FCF Margin (TTM)	-371.4%	N/A
Net Income (TTM)	$-411M	$-62M
FCF (TTM)	$-365M	$-37M
EPS (TTM)	-$6.91	-$4.30
ROE (TTM)	-3567.0%	-4784.0%
ROA (TTM)	-3306.0%	-3833.0%
ROIC (TTM)	-3567.0%	-4172.0%
Financial Health
Cash	$100M	$188M
Debt	$0	$22M
Net Cash/Debt	$100M	$166M
Current Ratio (TTM)	10.22x	21.18x
Quick Ratio (TTM)	9.14x	21.01x
Debt/Equity (TTM)	0.00x	0.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	-0.19
52W Performance	-25.3%	85.4%
YTD Performance	17.0%	38.4%
% from 52W High	-30.8%	-14.0%
% from 52W Low	43.0%	110.5%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.76x
FCF Yield (TTM)	-19.3%	-1.8%
Earnings Yield (TTM)	-21.7%	-3.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	-97.2
EV/GP/RG	0.06	N/A
Ticker research	View AGIO research	View PVLA research

Valuation

P/S Ratio

AGIO

19.24x

PVLA

46.64x

EV/FCF

PVLA

-49.96x

AGIO

-4.91x

Growth & revenue

Revenue Growth TTM

AGIO

140.6%

PVLA

-97.2%

Forward Revenue Growth

PVLA

287.4%

AGIO

92.6%

Profitability & performance

Gross Margin

AGIO

92.0%

PVLA

0.0%

ROE

AGIO

-3567.0%

PVLA

-4784.0%

FCF Yield %

PVLA

-1.8%

AGIO

-19.3%

52-Week Performance

PVLA

85.4%

AGIO

-25.3%

Detailed metrics comparison

AGIO

Agios Pharmaceuticals Inc

PVLA

Palvella Therapeutics Inc

Market Cap

AGIO$1.89B

PVLA$1.99B

Enterprise Value

AGIO$1.79B

PVLA$1.82B

Price

AGIO$31.81

PVLA$138.77

P/E Ratio

AGION/A

PVLAN/A

P/S Ratio

AGIO19.24x

PVLA46.64x

EV/Sales

AGIO18.22x

PVLA0.00x

EV/EBITDA

AGIO2.84x

PVLA0.00x

P/B Ratio

AGIO1.85x

PVLA8.80x

P/FCF Ratio

AGION/A

PVLAN/A

EV/FCF

AGIO-4.91x

PVLA-49.96x

PEG Ratio

AGION/A

PVLAN/A

Forward P/E (NTM)

AGION/A

PVLAN/A

Forward P/S (NTM)

AGIO6.91x

PVLAN/A

Revenue (TTM)

AGIO$98M

PVLA$0

Revenue Growth (YoY)

AGIO140.6%

PVLA-97.2%

Forward Rev Growth

AGIO92.6%

PVLA287.4%

Gross Margin (TTM)

AGIO92.0%

PVLA0.0%

Operating Margin (TTM)

AGIO0.0%

PVLA0.0%

EBITDA Margin (TTM)

AGIO-461.3%

PVLA0.0%

Net Margin (TTM)

AGIO-418.2%

PVLA0.0%

FCF Margin (TTM)

AGIO-371.4%

PVLAN/A

Net Income (TTM)

AGIO$-411M

PVLA$-62M

FCF (TTM)

AGIO$-365M

PVLA$-37M

EPS (TTM)

AGIO-$6.91

PVLA-$4.30

ROE (TTM)

AGIO-3567.0%

PVLA-4784.0%

ROA (TTM)

AGIO-3306.0%

PVLA-3833.0%

ROIC (TTM)

AGIO-3567.0%

PVLA-4172.0%

Cash

AGIO$100M

PVLA$188M

Debt

AGIO$0

PVLA$22M

Net Cash/Debt

AGIO$100M

PVLA$166M

Current Ratio (TTM)

AGIO10.22x

PVLA21.18x

Quick Ratio (TTM)

AGIO9.14x

PVLA21.01x

Debt/Equity (TTM)

AGIO0.00x

PVLA0.10x

Debt/Assets (TTM)

AGIO0.0%

PVLA0.0%

Interest Coverage (TTM)

AGION/A

PVLAN/A

Net Debt/EBITDA (TTM)

AGIO0.00x

PVLA0.00x

Beta

AGIO0.62

PVLA-0.19

52W Performance

AGIO-25.3%

PVLA85.4%

YTD Performance

AGIO17.0%

PVLA38.4%

% from 52W High

AGIO-30.8%

PVLA-14.0%

% from 52W Low

AGIO43.0%

PVLA110.5%

Asset Turnover (TTM)

AGIO0.08x

PVLA0.76x

FCF Yield (TTM)

AGIO-19.3%

PVLA-1.8%

Earnings Yield (TTM)

AGIO-21.7%

PVLA-3.1%

Dividend Yield (TTM)

AGION/A

PVLAN/A

Rule of 40

AGIO-230.8

PVLA-97.2

EV/GP/RG

AGIO0.06

PVLAN/A

Ticker research

View AGIO research View PVLA research

Metric	AGIO Agios Pharmaceuticals Inc	PVLA Palvella Therapeutics Inc
Market & Valuation
Market Cap	$1.89B	$1.99B
Enterprise Value	$1.79B	$1.82B
Price	$31.81	$138.77
P/E Ratio	N/A	N/A
P/S Ratio	19.24x	46.64x
EV/Sales	18.22x	0.00x
EV/EBITDA	2.84x	0.00x
P/B Ratio	1.85x	8.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.91x	-49.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.91x	N/A
Revenue & Growth
Revenue (TTM)	$98M	$0
Revenue Growth (YoY)	140.6%	-97.2%
Forward Rev Growth	92.6%	287.4%
Profitability
Gross Margin (TTM)	92.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-461.3%	0.0%
Net Margin (TTM)	-418.2%	0.0%
FCF Margin (TTM)	-371.4%	N/A
Net Income (TTM)	$-411M	$-62M
FCF (TTM)	$-365M	$-37M
EPS (TTM)	-$6.91	-$4.30
ROE (TTM)	-3567.0%	-4784.0%
ROA (TTM)	-3306.0%	-3833.0%
ROIC (TTM)	-3567.0%	-4172.0%
Financial Health
Cash	$100M	$188M
Debt	$0	$22M
Net Cash/Debt	$100M	$166M
Current Ratio (TTM)	10.22x	21.18x
Quick Ratio (TTM)	9.14x	21.01x
Debt/Equity (TTM)	0.00x	0.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	-0.19
52W Performance	-25.3%	85.4%
YTD Performance	17.0%	38.4%
% from 52W High	-30.8%	-14.0%
% from 52W Low	43.0%	110.5%
Efficiency & Yields
Asset Turnover (TTM)	0.08x	0.76x
FCF Yield (TTM)	-19.3%	-1.8%
Earnings Yield (TTM)	-21.7%	-3.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-230.8	-97.2
EV/GP/RG	0.06	N/A
Ticker research	View AGIO research	View PVLA research